Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,Cystic Fibrosis Knowledge Centre

    Launch of the Cystic Fibrosis Knowledge Centre

    This new resource has been developed to support healthcare professionals
    in the treatment of patients with cystic fibrosis (CF).
    It contains a host of clinical information including a disease awareness section,
    emerging and supportive therapeutic options and current best practice
    based on recently updated guidelines by the
    European Cystic Fibrosis Society (ECFS).

  • ,CLL What's New

    New case-based chronic lymphocytic leukaemia
    CME module

    A new CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been
    added to the CLL Knowledge Centre on epgonline.org. Read case studies and improve
    your knowledge of CLL by answering quiz questions based on a variety of scenarios. This
    module has been EACCME-accredited and is worth 1 European CME credit. There is
    no cost to complete this educational activity.

  • ,Hypogonadism Relaunch Whats New

    Launch of updated Hypogonadism Knowledge Centre

    Our Hypogonadism Knowledge Centre contains important disease awareness
    information to support healthcare professionals in the current best practice
    treatment and management of male hypogonadism and is available to access free of
    charge. Sections cover epidemiology, pathophysiology, signs and symptoms, treatment
    options, as well as useful resources and a regularly updated publications digest.


  • ,

    New Type 2 Diabetes CME now available

    A new CME activity ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in
    Combination with Insulin’ has been added to the Type 2 Diabetes Learning Zone.
    Complete the five modules to enhance your understanding of the combination
    therapies available for treating type 2 diabetes.

  • ,COPD whats new ATS 2015

    ATS 2015 symposium materials added to
    COPD Knowledge Centre

    Speaker slides and a video from the Novartis-sponsored symposium ‘Are we gaining the
    maximum benefit from bronchodilators in COPD?’ have been added to the COPD Knowledge
    Centre. The session was held at the American Thoracic Society (ATS) conference 2015 to
    highlight the fundamental role of bronchodilators in COPD management, and presented
    key drug data including efficacy and safety of some of the latest COPD therapies.

Latest News

FDA Arthritis Advisory Committee recommends CTP 13 (infliximab biosimilar)for all indications of the reference product - Hospira/Pfizer


The FDA Arthritis Advisory Committee has approved the investigational biosimilar infliximab (CT-P13) across all eligible indications by a vote of 21 to three. Celltrion's proposed biosimilar infliximab, to which Pfizer/Hospira holds exclusive ...

Phase III trial of elagolix in endometriosis meets primary endpoint- AbbVie/Neurocrine Biosciences


AbbVie and Neurocrine Biosciences have announced positive top-line results from the second of two replicate pivotal Phase III clinical trials evaluating the efficacy and safety of Elagolix in premenopausal women who suffer pain from endometriosis. ...

New Drug Application for SB 1518(pacritinib) for myelofibrosis withdrawn after FDA announces clinical hold on trials- CTI BioPharma


Following the partial clinical hold announced in February 2016 by the FDA regarding its clinical studies of SB 1518 (pacritinib) for Myelofibrosis, CTI BioPharma received communication from the FDA notifying the Company that its IND for pacritinib ...

NICE does not recommend 3 molecular tests for sepsis


In final diagnostics guidance published NICE has recommended that further research is carried out on 3 promising new blood tests for speeding up the identification of bloodstream bacteria and fungi in people with suspected Sepsis or bloodstream ...

SLIT-tablet filed with FDA for house dust mite allergy- Merck


Merck has submitted a Biologics License Application (BLA) to the FDA for its house dust mite (HDM) sublingual allergy immunotherapy tablet (SLIT-tablet). The application to the FDA is based on results from an extensive clinical development programme ...

Phase III study of Alecensa (alectinib) in non small cell lung cancer meets endpoint and halted early- Chugai Pharmaceutical


Chugai Pharmaceutical has received a recommendation by an independent data monitoring committee (IDMC) that the J-ALEX Study, a phase III study of Alecensa (alectinib) targeting ALK fusion gene positive non-small cell lung cancer (NSCLC) being ...

Data from phase III ENERGITO study of Stiolto Respimat (olodaterol + tiotropium) published in journal of chronic obstructive pulmonary disease- Boehringer


Boehringer has announced the publication of data that show Stiolto Respimat (olodaterol + tiotropium) improved lung function across a range of measures (FEV1 AUC0–12, FEV1 AUC0–24, FEV1 AUC12–24, peak0-3 FEV1 and trough FEV1) in ...

Recent Updates


Clinical Guidelines

Myeloma: diagnosis and management

Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over


Care of dying adults in the last days of life

Medical Journals


Imatinib: a breakthrough of targeted therapy in cancer.

Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?

Dulaglutide (LY-2189265) for the treatment of type 2 diabetes.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages



News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors